Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Gene variants of adhesion molecules predispose to MS: A case-control study.

Dardiotis E, Panayiotou E, Siokas V, Aloizou AM, Christodoulou K, Hadjisavvas A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Genet. 2019 Jan 16;5(1):e304. doi: 10.1212/NXG.0000000000000304. eCollection 2019 Feb.

2.

Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset.

Andreou S, Panayiotou E, Michailidou K, Pirpa P, Hadjisavvas A, El Salloukh A, Barnes D, Antoniou A, Agathangelou P, Papastavrou K, Christodoulou K, Tanteles GA, Kyriakides T.

Amyloid. 2018 Dec;25(4):220-226. doi: 10.1080/13506129.2018.1534731. Epub 2018 Dec 20.

PMID:
30572722
3.

Sequential Role of SOXB2 Factors in GABAergic Neuron Specification of the Dorsal Midbrain.

Makrides N, Panayiotou E, Fanis P, Karaiskos C, Lapathitis G, Malas S.

Front Mol Neurosci. 2018 May 8;11:152. doi: 10.3389/fnmol.2018.00152. eCollection 2018.

4.

Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy.

Panayiotou E, Papacharalambous R, Antoniou A, Christophides G, Papageorgiou L, Fella E, Malas S, Kyriakides T.

Biochem Biophys Rep. 2016 Aug 11;8:48-54. doi: 10.1016/j.bbrep.2016.08.005. eCollection 2016 Dec.

5.

Ventilator respiratory graphic diagnosis of hiccupping in non-ketotic hyperglycinaemia.

Panayiotou E, Spike K, Morley C, Belteki G.

BMJ Case Rep. 2017 Aug 9;2017. pii: bcr-2017-220267. doi: 10.1136/bcr-2017-220267.

6.

The effects of grazing intensity on soil processes in a Mediterranean protected area.

Panayiotou E, Dimou M, Monokrousos N.

Environ Monit Assess. 2017 Aug 8;189(9):441. doi: 10.1007/s10661-017-6161-6.

PMID:
28791504
7.

Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy.

Fella E, Sokratous K, Papacharalambous R, Kyriacou K, Phillips J, Sanderson S, Panayiotou E, Kyriakides T.

Front Mol Neurosci. 2017 May 10;10:138. doi: 10.3389/fnmol.2017.00138. eCollection 2017.

8.

Gene variants of adhesion molecules act as modifiers of disease severity in MS.

Dardiotis E, Panayiotou E, Provatas A, Christodoulou K, Hadjisavvas A, Antoniades A, Lourbopoulos A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 24;4(4):e350. doi: 10.1212/NXI.0000000000000350. eCollection 2017 Jul.

9.

C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.

Panayiotou E, Fella E, Papacharalambous R, Malas S, Saraiva MJ, Kyriakides T.

PLoS One. 2017 Apr 13;12(4):e0175767. doi: 10.1371/journal.pone.0175767. eCollection 2017.

10.

Vsx1 Transiently Defines an Early Intermediate V2 Interneuron Precursor Compartment in the Mouse Developing Spinal Cord.

Francius C, Hidalgo-Figueroa M, Debrulle S, Pelosi B, Rucchin V, Ronellenfitch K, Panayiotou E, Makrides N, Misra K, Harris A, Hassani H, Schakman O, Parras C, Xiang M, Malas S, Chow RL, Clotman F.

Front Mol Neurosci. 2016 Dec 26;9:145. doi: 10.3389/fnmol.2016.00145. eCollection 2016.

11.

Centipede assemblages along an urbanization gradient in the city of Heraklion, Crete (Greece).

Papastefanou G, Panayiotou E, Mylonas M, Simaiakis SM.

Zookeys. 2015 Jun 30;(510):163-79. doi: 10.3897/zookeys.510.8414. eCollection 2015.

12.

Adult spinal cord ependymal layer: a promising pool of quiescent stem cells to treat spinal cord injury.

Panayiotou E, Malas S.

Front Physiol. 2013 Nov 28;4:340. doi: 10.3389/fphys.2013.00340. Review.

13.

Pax6 is expressed in subsets of V0 and V2 interneurons in the ventral spinal cord in mice.

Panayiotou E, Panayi E, Lapathitis G, Francius C, Clotman F, Kessaris N, Richardson WD, Malas S.

Gene Expr Patterns. 2013 Dec;13(8):328-34. doi: 10.1016/j.gep.2013.06.004. Epub 2013 Jun 29.

PMID:
23816521
14.

Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration.

Dardiotis E, Panayiotou E, Feldman ML, Hadjisavvas A, Malas S, Vonta I, Hadjigeorgiou G, Kyriakou K, Kyriakides T.

Neurosci Lett. 2013 Aug 26;548:170-5. doi: 10.1016/j.neulet.2013.05.058. Epub 2013 Jun 5.

PMID:
23748038
15.

Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.

Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K.

Eur Radiol. 2012 Apr;22(4):796-802. doi: 10.1007/s00330-011-2319-8. Epub 2011 Nov 17.

PMID:
22086561
16.

21 Mb deletion in chromosome band 13q22.2q32.1 associated with mild/moderate psychomotor retardation, growth hormone insufficiency, short neck, micrognathia, hypotonia, dysplastic ears and other dysmorphic features.

Grigori P, Panayiotou E, Sismani C, Koumbaris G, Ioannides M, Costalos C, Kosmaidou-Aravidou Z, Kousoulidou L, Patsalis PC.

Eur J Med Genet. 2011 May-Jun;54(3):365-8. doi: 10.1016/j.ejmg.2011.02.006. Epub 2011 Feb 24.

PMID:
21354346
17.

Sox1 maintains the undifferentiated state of cortical neural progenitor cells via the suppression of Prox1-mediated cell cycle exit and neurogenesis.

Elkouris M, Balaskas N, Poulou M, Politis PK, Panayiotou E, Malas S, Thomaidou D, Remboutsika E.

Stem Cells. 2011 Jan;29(1):89-98. doi: 10.1002/stem.554.

18.

Sox1 is required for the specification of a novel p2-derived interneuron subtype in the mouse ventral spinal cord.

Panayi H, Panayiotou E, Orford M, Genethliou N, Mean R, Lapathitis G, Li S, Xiang M, Kessaris N, Richardson WD, Malas S.

J Neurosci. 2010 Sep 15;30(37):12274-80. doi: 10.1523/JNEUROSCI.2402-10.2010.

19.

Clinical evaluation of a phalangeal bone mineral density assessment system.

Patel R, Blake GM, Panayiotou E, Fogelman I.

J Clin Densitom. 2010 Jul-Sep;13(3):292-300. doi: 10.1016/j.jocd.2010.04.001. Epub 2010 Jun 2.

PMID:
20554233
20.

SOX1 links the function of neural patterning and Notch signalling in the ventral spinal cord during the neuron-glial fate switch.

Genethliou N, Panayiotou E, Panayi H, Orford M, Mean R, Lapathitis G, Gill H, Raoof S, De Gasperi R, Elder G, Kessaris N, Richardson WD, Malas S.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1114-20. doi: 10.1016/j.bbrc.2009.08.154. Epub 2009 Aug 31.

PMID:
19723505
21.

Generation of an ABCG2(GFPn-puro) transgenic line--a tool to study ABCG2 expression in mice.

Orford M, Mean R, Lapathitis G, Genethliou N, Panayiotou E, Panayi H, Malas S.

Biochem Biophys Res Commun. 2009 Jun 26;384(2):199-203. doi: 10.1016/j.bbrc.2009.04.089. Epub 2009 Apr 23.

PMID:
19393620
22.

Spatially distinct functions of PAX6 and NKX2.2 during gliogenesis in the ventral spinal cord.

Genethliou N, Panayiotou E, Panayi H, Orford M, Mean R, Lapathitis G, Malas S.

Biochem Biophys Res Commun. 2009 Apr 24;382(1):69-73. doi: 10.1016/j.bbrc.2009.02.134. Epub 2009 Mar 1.

PMID:
19258013
23.

A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations.

Blake GM, Chinn DJ, Steel SA, Patel R, Panayiotou E, Thorpe J, Fordham JN; National Osteoporosis Society Bone Densitometry Forum.

Osteoporos Int. 2005 Dec;16(12):2149-56. Epub 2005 Oct 15.

PMID:
16228104

Supplemental Content

Loading ...
Support Center